Vitamin D Status and Adiposity in Pediatric Malabsorption Syndromes

Benjamin Udoka Nwosu1, Louise Maranda

  • 1Department of Pediatrics, University of Massachusetts Medical School, Worcester, Mass., USA.

Digestion
|June 6, 2015
PubMed

Insights

In pediatric malabsorption syndromes, adiposity does not affect vitamin D levels. This study found no link between body weight and serum 25-hydroxyvitamin D (25(OH)D) in children with conditions like celiac disease.

Area of Science:

  • Pediatric Endocrinology
  • Nutritional Science
  • Gastroenterology

Background:

  • Vitamin D status is crucial for bone health and immune function in children.
  • The interplay between nutrient malabsorption, adiposity, and vitamin D levels remains poorly understood in pediatric populations.
  • Conditions like celiac disease (CD), lactose intolerance (LI), and inflammatory bowel disease (IBD) can impair nutrient absorption.

Purpose of the Study:

  • To investigate the relationship between body mass index (BMI)-defined adiposity and serum 25-hydroxyvitamin D (25(OH)D) concentrations.
  • To determine if adiposity influences vitamin D status in children with malabsorption disorders.
  • To compare these associations in children with LI, CD, and IBD versus healthy controls.

Main Methods:

  • Cross-sectional study comparing pediatric patients (ages 3-16) with LI, CD, or IBD to healthy controls.
  • Serum 25(OH)D levels were measured, and vitamin D deficiency was defined as <50 nmol/l.
  • Adiposity was categorized using BMI percentiles: overweight (≥85th to <95th) and obesity (≥95th).

Main Results:

  • In healthy controls, normal-weight individuals had significantly higher 25(OH)D levels than overweight/obese individuals.
  • Conversely, no significant differences in 25(OH)D concentrations were observed between normal-weight and overweight/obese patients with LI, CD, or IBD.
  • These findings indicate a dissociation between adiposity and vitamin D status in pediatric malabsorption syndromes.

Conclusions:

  • Adiposity is not associated with serum 25-hydroxyvitamin D levels in pediatric patients with malabsorption disorders.
  • The mechanisms underlying vitamin D regulation may differ in children with malabsorption compared to healthy children.
  • Further research is needed to explore factors influencing vitamin D status in these specific pediatric populations.
Abstract

Related Concept Videos

Role of Skin in Vitamin D Synthesis01:23

Role of Skin in Vitamin D Synthesis

The skin plays a crucial role in the synthesis of vitamin D, a vital nutrient for various physiological processes in the body. Vitamin D is unique because it can be synthesized in the skin through a series of chemical reactions triggered by exposure to ultraviolet B (UVB) radiation from sunlight.
The solar UV B rays (290-315 nm) are absorbed by the skin, and 7-dehydrocholesterol (provitamin D3) photolyzes it to previtamin D3, which undergoes a rapid transformation to vitamin...
8.9K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
821
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
404
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
4.8K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
497
Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
3.1K